DENVER, CO / ACCESS Newswire / February 20, 2026 / ForCast Orthopedics, a development-stage company focused on modernizing care for complex orthopedic infections, today announced that its team and technology will be featured in upcoming media events produced by the Anterior Hip Foundation (AHF) and the Journal of Orthopaedic Experience & Innovation (JOEI).
The AHF podcast series From Idea to Market is a 12-episode, documentary-style series exploring how medical innovation happens. The series includes interview excerpts with ForCast team members Peter Noymer, PhD (CEO), Jared Foran, MD (CSO), and Leo Whiteside, MD (scientific advisor), as they talk about their experiences conceiving and developing ForCast's novel approach to treating periprosthetic joint infection (PJI).
"We are very excited for the launch of the AHF From Idea to Market series," said Peter Noymer, PhD, Executive Chairman and CEO of ForCast Orthopedics. "The topics that the AHF team covered in the series are extremely relevant to the journey that we're on with our groundbreaking PJI treatment. We found it gratifying to share our story, and we hope that it will inspire listeners to bring forward other innovations to benefit patients."
In addition to being highlighted in the AHF podcast series, ForCast team members will participate in a panel discussion hosted by JOEI titled PJI 2.0: Direct Intra-Articular Antibiotics Kill Biofilm & Infection. ForCast scientific advisors Matthew P. Abdel, MD, and R. Michael Meneghini, MD, will be sharing their insight into the challenges with the current standard of care for PJI treatment, and how technologies such as ForCast's that focus on the root causes of PJI could elevate the standard of care and dramatically improve outcomes for patients.
The AHF From Idea to Market podcast series debuts on February 20th and will run through June 12th. A recording of the extended interview with the ForCast team will become available on March 24th. Episodes can be accessed via the following links:
https://ahfpodcast.buzzsprout.com/
https://www.youtube.com/@anteriorhipfoundation
The JOEI panel discussion will air at 8:00 pm Eastern time on Wednesday, February 25th and can be accessed via the following link: https://us02web.zoom.us/meeting/register/J0taMbLTRDuuPI6EepZ4Aw#/registration
About ForCast Orthopedics
ForCast is a development-stage company with a focus on pioneering the treatment of periprosthetic joint infection (PJI) with targeted antibiotic therapies. The Company's mission is to modernize the standard of care for PJI and to provide better treatments and improved outcomes for the growing population of joint replacement patients.
Contact:
Peter Noymer, PhD
Executive Chairman and CEO
pnoymer@forcastortho.com
SOURCE: ForCast Orthopedics
View the original press release on ACCESS Newswire
